HomepageFDMDF • OTCMKTS
add
4DMedical Ltd
Vorige slotkoers
$Â 3,16
Jaar-range
$Â 0,16 - $Â 3,16
Beurswaarde
2,66Â mld. AUD
Gem. volume
135,00
Koers/winst
-
Dividendrendement
-
Primaire beurs
ASX
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (AUD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 1,43Â mln. | -1,49% |
Bedrijfskosten | 14,59Â mln. | 11,31% |
Netto inkomsten | -77,07Â mln. | -1.265,93% |
Netto winstmarge | -5,40K | -1.286,55% |
Winst per aandeel | — | — |
EBITDA | -12,66Â mln. | -20,94% |
Effectief belastingtarief | 0,60% | — |
Balans
Totale activa
Totale passiva
| (AUD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 56,76Â mln. | 255,84% |
Totale activa | 139,55Â mln. | 36,79% |
Totale passiva | 167,95Â mln. | 298,46% |
Totaal aandelenvermogen | -28,40 mln. | — |
Uitstaande aandelen | 534,17 mln. | — |
Koers-boekwaardeverhouding | -63,20 | — |
Rendement op activa | -23,75% | — |
Rendement op kapitaal | 182,54% | — |
Kasstroom
Nettomutatie in liquide middelen
| (AUD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -77,07Â mln. | -1.265,93% |
Operationele kasstroom | -6,33Â mln. | 10,52% |
Kasstroom uit beleggingen | -419,72K | 0,67% |
Kasstroom uit financiering | 31,69Â mln. | 18.541,71% |
Nettomutatie in liquide middelen | 24,94Â mln. | 440,39% |
Vrije kasstroom | -47,08Â mln. | -662,91% |
Over
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Opgericht
2013
Website
Werknemers
124